Limited coverage drugs – rotigotine
Last updated on August 7, 2024
| Generic name | rotigotine | |
| Strength | 2 mg/24h, 4 mg/24h, 6 mg/24h, 8 mg/24h | |
| Form | transdermal patch | |
| Special Authority criteria | Approval period |
|---|---|
|
For the treatment of advanced-stage Parkinson’s disease, when the patient is receiving treatment with levodopa and requires additional adjunctive therapy. |
Indefinite |
Practitioner exemptions
- None
Special notes
- PharmaCare does not provide coverage of rotigotine for restless leg syndrome.